Latest Johnson & Johnson Stories
Court documents indicate more than 7,300 DePuy Pinnacle hip lawsuits have been filed in the federal litigation on behalf of individuals who were allegedly harmed by a metal-on-metal version of
-- Additional Five Companies Awarded Residency at JLABS @SSF Through Quick Fire Challenge -- SAN FRANCISCO, March 3, 2015 /PRNewswire/ -- Johnson & Johnson Innovation LLC today
GBCHealth, a prominent business coalition with a long history of catalyzing private sector activities and investments in global health issues, today announced that it has recently elected four
NEW BRUNSWICK, N.J., March 2, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced a binding offer from Cardinal Health to acquire its Cordis business for an
Pharmaceutical manufacturer, Johnson & Johnson, loses $2.5 million verdict for marketing of Risperdal, a potent antipsychotic that caused female breast growth in a young boy the case revealed.
New Patient Athlete(TM) Program Demonstrates Comprehensive Approach to Driving Sustained Behavior Change and Improved Outcomes NEW BRUNSWICK, N.J., Feb.
CRANFIELD, England, February 26, 2015 /PRNewswire/ -- Now in its fifth year, the Productive Innovation Index (PII) celebrates the top 30 pharmaceutical companies most successful
DALLAS, February 26, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Strongyloidiasis Global Clinical Trials Review, H2, 2014" market research report to its store.
Lawsuit website reports recent announcement by Bayer and Johnson & Johnson that they will push for further FDA approvals for Xarelto, while lawsuits against them are consolidated in multidistrict litigation
- a slit in a tire to drain away surface water and improve traction.